Subject: Newsflash: CDC is a Risk to the US Blood Supply
Date: Sep 6, 2011 1:20 PM
ARTICLE BELOW
=================================
This all means that Yale's Peter Krause
*** won't be able to qualify his Babesia
vaccine with any antibody testing.***
That makes the CDC a risk to human health
at large, nevermind the blood supply. The
CDC staff (Barbara Johnson) is patently
involved in the Lyme testing scam:
http://www.actionlyme.org/CDCS_PARTICIPATION_IN_LYME_CRIMES.htm
Note (below) that the Chinese really pay attention
to the important stuff... like contaminated
childhood vaccines, LOL - contaminated with
*IMMUNOSUPPRESSIVE MYCOPLASMA* - same stuff
as LYMErix...
----------------------------------
Most vector-borne diseases are bearers
of TLR2 agonists (like LYMErix), which
after a while render the host seronegative
(or, make no antibodies against the disease;
Hat Tip to UConn's Justin Radolf for
explaining how Lyme and LYMErix are
seronegative:
http:/www.actionlyme.org/PIIB.htm
http://www.jimmunol.org/cgi/content/full/167/2/910
"Toll-like receptor 2-dependent inhibition of macrophage class II MHC
expression and antigen processing by 19-kDa lipoprotein of
Mycobacterium tuberculosis." -- Justin Radolf
-----------------
Babesia/Malaria are seronegative:
http://www.ncbi.nlm.nih.gov/pubmed?term=19910051
(The Chronic agonism of TLR2 - according
to Justin Radolf - renders no antibodies).
------------------
Vaccination of Children with Mycoplasma
Contamimated Vaccines (Hat Tip to
the Chinese):
http://www.ncbi.nlm.nih.gov/pubmed/21864704
----------------------------
Peeps who take the TNF-inhibitors for
Rheumatoid Arthritis or Psoriasis
are at risk for LYMErix-Disease:
"Neurological Deficits During Treatment With Tumor Necrosis Factor-
Alpha Antagonists."
http://www.ncbi.nlm.nih.gov/pubmed/21876428
"SEEMS TO BE ACTIVATED EPSTEIN-BARR, HO-HUMM,
LIKE THE NEW GREAT IMITATORS/IMMUNOSUPPRESSION:
http://www.actionlyme.org/CHP_9_IDSA_REVIEWS.htm "
--------------------------------
http://www.chicagotribune.com/health/sns-rt-us-parasite-bloodtre784473-20110905,0,5092174.story
HICAGO (Reuters) - A tick-borne infection known as Babesiosis, which
can cause severe disease and even death, is becoming a growing threat
to the U.S. blood supply, government researchers said on Monday.
There are currently no diagnostic tests approved by the U.S. Food and
Drug Administration that can detect the infection before people donate
blood.
* Related
* Stem cells for broken hearts Story: Stem cells for broken hearts
* Photos: The seven guidelines for heart health Photos: Photos:
The seven guidelines for heart health
* How to tell if you're having a heart attack Story: How to tell
if you're having a heart attack
* Database: How many calories are in your restaurant meal? Story:
Database: How many calories are in your restaurant meal?
* Topics
* Symptoms
* Blood
* Human Body
* See more topics »
o
X
U.S. Centers for Disease Control and Prevention
Diseases and Illnesses
Emergency Health Procedures
Premature Birth
Health Organizations
Chills
Food and Drug Administration
Health and Medical Professionals
Fever
Internists
Internal Medicine
A 31-year study by the Centers for Disease Control and Prevention now
suggests the parasitic infection may be increasing.
Babesia infections are marked by anemia,fever, chills and fatigue, but
they can also cause organ failure and death.
The still rare disease is known to occur in seven U.S. states in the
Northeast and Upper Midwest in the spring and summer.
But a study led by Dr. Barbara Herwaldt of the CDC, published in the
Annals ofInternal Medicine, found cases had occurred year-round and in
states where Babesia parasites are not found -- including as far away
as Texas and Florida.
States in which the parasite occurs naturally are Massachusetts, New
York, Connecticut, Minnesota, Rhode Island, New Jersey and Wisconsin.
Of the 162 cases of Babesia infection caused by blood transfusions
between 1979 and 2009, nearly 80 percent occurred between 2000 and
2009.
"Babesia microti has become the most frequently reported transfusion-
transmitted parasite in the United States," CDC researchers wrote, far
outpacing malaria infections, which accounted for 49 cases of
transfusion-associated disease during the same period, including just
five cases during 2000-2009.
Premature infants appear to be especially vulnerable.
A separate study published on Monday in the journal Pediatrics by a
team at the University of Nebraska looked at seven cases of
transfusion-associated Babesiosis in premature infants.
They found blood transfusions from two infected units of blood caused
all seven of the cases of Babesiosis.
Symptoms of the infections varied widely, but babies with the lowest
weights at birth were at greatest risk of serious infection.
The authors warned doctors in areas in which Babesiosis occurs to be
watchful for cases in premature infants exposed to blood transfusions.
The CDC researchers called for better ways to prevent and detect cases
of transfusion-associated Babesiosis.
"Our findings underscore the year-round vulnerability of the U.S.
blood supply -- especially, but not only -- in and near Babesiosis-
endemic areas.
"They also highlight the importance of multi-agency collaborative
efforts to detect, investigate, and document transfusion cases; to
assess the risks for transfusion transmission; and, thereby, to inform
the scope of prevention measures."
To deter transfusion-linked Babesiosis, the CDC in January said public
health departments should report all cases of the infections to the
CDC.
(Editing by Peter Cooney)
Copyright © 2011, Reuters
sns-rt-us-parasite-bloodtre784473-20110905
KMDickson